Today, Invictus MD Strategies Corp. (CSE:IMH; OTC:IVITF; FRA:8IS) announced that it has entered into a binding letter of intent to acquire 100% of PlanC BioPharm, a applicant to become a Licensed Producer in Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR).